UK markets closed
NIKKEI 225
29,222.77 +353.86 (+1.23%) HANG SENG
19,922.45 +91.93 (+0.46%) CRUDE OIL
87.20 +0.67 (+0.77%) GOLD FUTURES
1,774.20 -15.50 (-0.87%) DOW
33,968.05 -183.96 (-0.54%) BTC-GBP
19,466.14 -392.17 (-1.97%)
CARA Jan 2024 2.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:35PM EDT. Market open.
| Previous close | 10.50 |
| Open | 10.50 |
| Bid | 6.50 |
| Ask | 11.50 |
| Strike | 2.50 |
| Expiry date | 2024-01-19 |
| Day's range | 10.50 - 10.50 |
| Contract range | N/A |
| Volume | |
| Open interest | 6 |
- Zacks
Cara Therapeutics (CARA) Reports Q2 Loss, Tops Revenue Estimates
Cara (CARA) delivered earnings and revenue surprises of 71.43% and 8.08%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Should You Buy Cara Therapeutics (CARA) Ahead of Earnings?
Cara Therapeutics (CARA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- Simply Wall St.
Investors in Cara Therapeutics (NASDAQ:CARA) have unfortunately lost 56% over the last three years
Cara Therapeutics, Inc. ( NASDAQ:CARA ) shareholders should be happy to see the share price up 18% in the last month...
© 2022 Yahoo. All rights reserved.
